Epilepsy Talk
What’s really in your meds?
July 5, 2022
1 Comment
1 Comment
As Americans become more concerned about quality issues with prescription medications made abroad, one company is trying to offer an additional layer of reassurance — by doing chemical analysis before dispensing drugs to patients.
Posted in Epilepsy, Medication Issues, Research
Tags: anti-convulsant medications, chemical analysis, China, consistency, contaminents, correct dosage, FDA, generics and name brand drugs, global drug supply, India, level of quality control, media attention, pharmaceutical supply chain, prescription medications, quality data, quality issues, quality scores, ranking manufacturers, relapses, safety, side effects, third-party check, variability
Tags: anti-convulsant medications, chemical analysis, China, consistency, contaminents, correct dosage, FDA, generics and name brand drugs, global drug supply, India, level of quality control, media attention, pharmaceutical supply chain, prescription medications, quality data, quality issues, quality scores, ranking manufacturers, relapses, safety, side effects, third-party check, variability
About the author
Epilepsy Talk 